Parenteral Nutrition Market Size
The global parenteral nutrition market size was estimated at approximately USD 8.02 billion in 2025 and is projected to reach around USD 12.72 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2026–2033.
Parenteral nutrition is a method of getting nutrition into the body through the veins, which include amino acids, carbohydrates, fat, minerals and electrolytes, vitamins, trace elements, and others. for patients who cannot eat or absorb enough food through tube feeding formula or by mouth to maintain proper nutrition status. It is delivered either peripherally or centrally, through the superior vena cava, this helps in crossing the first-pass effect.
Parenteral Nutrition Market Scope
| Metrics | Details |
| CAGR | 5.8% |
| Size Available for Years | 2025-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | By Type, End User, Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Orthopedic Surgery key Insights. |
For More Inisghts about the Market Request Free Sample
Parenteral Nutrition Market Dynamics
The increasing occurrence of chronic conditions, such as cancer, is influencing the global parenteral nutrition market positively. The benefit of parenteral nutrition in chronic diseases helps in the provision of vital nutrients that help in maintaining the hydration level, strength, and energy to the patients. According to the International Agency for Research on Cancer (IARC), in 2018 there were 17.0 million new cancer cases worldwide, by 2040, it is expected to reach 27.5 million new cancer cases due to the growth and aging of the population. Thus, the increase in cancer cases is expected to drive the global parenteral nutrition market.
The rise in pediatric disorders will create mineral and vitamin deficiencies amongst children that will fuel the demand for parenteral nutrition products, thereby increasing the market growth. Additionally, extensive research and development activities by key players to develop new parenteral nutrition products and rising approvals to new parenteral nutrition components drive the market. In October 2018, Baxter in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN) launched the ‘smartPN’ tool to reduce clinical malnutrition.
Parenteral Nutrition Market Segmentation Analysis
Based on type- the global Parenteral Nutrition market is broadly segmented as amino acid, fats, minerals & vitamins, parenteral lipid emulsions, trace elements, and others. Among all, amino acids accounted for a major market share in 2024 and are projected to grow at a high CAGR over the forecast period (2025-2031). It is due to increasing cases of renal insufficiency, hepatic insufficiency, and protein-catabolic critical illness that will globally boost the demand for amino acid-based parenteral nutrition products.
Additionally, deficiency of energy and dietary proteins are customary in critically-ill hospitalized patients that ultimately lead to protein-energy malnutrition. Over the forecast period, parenteral lipid emulsion is expected to grow at a significant rate. Lipid emulsions are prescribed for pediatric patients as they are a non-carbohydrate source of energy. These lipid emulsions are a rich source of essential fatty acids. Also useful in maintaining overall nitrogen balance in parenteral nutrition solutions.
Parenteral Nutrition Market Geographical Share
The global Parenteral Nutrition market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region accounted for major market share in 2025 and is projected to grow at a significant rate during the forecast period (2025-2031).
The region will witness positive growth owing to a rise in awareness about parenteral nutrition, increasing incidence of chronic diseases coupled with rising healthcare expenses, the existence of advanced healthcare facilities, as well as favorable reimbursement policies. Asia Pacific is projected to grow at a significant pace over the forecast period, owing to the rapidly increasing population prone to malnutrition, rise in awareness among people, and modernizing of healthcare infrastructure in developing nations such as China and India in this region.
Parenteral Nutrition Manufacturers and Competition Landscape
Significant players of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, B. Braun Melsungen AG, Pfizer, Inc., and others. The product launches, collaboration, and product agreements, and other key developments are the dominating strategies adopted by the market players to enhance their product portfolio in the parenteral nutrition market. For instance, in October 2018, Fresenius Kabi Announced U.S. Availability of Omegaven® (fish oil triglycerides) Injectable Emulsion.
Recent Developments
- May 2026: Baxter International Inc. expanded its global parenteral nutrition portfolio with advanced lipid emulsion and multi-chamber bag solutions aimed at improving patient safety and reducing infection risks in critical care settings.
- April 2026: Fresenius Kabi strengthened its clinical nutrition manufacturing capacity in Europe and Asia to meet rising demand for hospital-based parenteral nutrition therapies.
- March 2026: B. Braun Melsungen AG introduced enhanced all-in-one parenteral nutrition formulations with improved micronutrient stability and longer shelf-life for intensive care applications.
- February 2026: Otsuka Pharmaceutical Co., Ltd. advanced research in pediatric and neonatal parenteral nutrition solutions focusing on precision electrolyte balance and improved metabolic outcomes.
- January 2026: Pfizer Inc. expanded hospital nutrition collaborations to support critical-care parenteral feeding protocols in oncology and post-surgical recovery patients.
- December 2025: Grifols S.A. enhanced sterile compounding and infusion safety systems supporting large-scale parenteral nutrition preparation in hospital pharmacies.
- November 2025: Sichuan Kelun Pharmaceutical Co., Ltd. increased production of parenteral nutrition infusion bags to support growing demand in Asia-Pacific healthcare facilities.
- October 2025: Abbott Laboratories expanded its clinical nutrition product line to include improved amino acid formulations supporting critical care and long-term hospitalization patients.
- September 2025: OliX Pharmaceuticals (Correction applied below for relevance)
- September 2025 (Corrected): Vifor Pharma strengthened partnerships with hospitals to improve parenteral nutrition delivery systems and reduce catheter-related complications.
- August 2025: Hikma Pharmaceuticals expanded injectable manufacturing capabilities supporting high-quality sterile parenteral nutrition components for global hospital supply chains.
